UnitedHealth Group Incorporated (UNH) Holdings Reduced by Telemus Capital LLC
Telemus Capital LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,437 shares of the healthcare conglomerate’s stock after selling 69 shares during the period. UnitedHealth Group accounts for about 0.8% of Telemus Capital LLC’s investment portfolio, making the stock its 19th biggest position. Telemus Capital LLC’s holdings in UnitedHealth Group were worth $6,200,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in the business. Patriot Financial Group Insurance Agency LLC increased its holdings in shares of UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Kings Point Capital Management raised its stake in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the last quarter. Founders Capital Management bought a new position in shares of UnitedHealth Group in the first quarter valued at approximately $135,000. Parkside Financial Bank & Trust raised its stake in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after acquiring an additional 12 shares during the last quarter. Finally, Hanson McClain Inc. boosted its holdings in shares of UnitedHealth Group by 1.7% in the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after acquiring an additional 15 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.
WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/03/unitedhealth-group-incorporated-unh-holdings-reduced-by-telemus-capital-llc.html.
A number of equities research analysts recently commented on UNH shares. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Cantor Fitzgerald reissued a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, August 29th. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Finally, Jefferies Group LLC restated a “buy” rating and set a $215.00 target price on shares of UnitedHealth Group in a report on Friday, August 18th. Two research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $203.59.
UnitedHealth Group Incorporated (NYSE UNH) opened at 197.44 on Tuesday. The company has a market cap of $190.90 billion, a PE ratio of 23.72 and a beta of 0.63. The stock’s 50 day moving average price is $195.77 and its 200 day moving average price is $182.90. UnitedHealth Group Incorporated has a 12-month low of $133.03 and a 12-month high of $200.76.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same period last year, the business posted $1.96 EPS. The business’s revenue was up 7.7% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is 35.13%.
In related news, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock worth $14,981,909 over the last three months. 0.89% of the stock is owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.